Nassim Djebli

8PUBLICATIONS
12CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)PharmacogenomicsSolid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 11, 2026
Population Pharmacokinetics of Trastuzumab Rezetecan in Patients With HER2-Expressing or Mutated Advanced Solid Tumors.

|Mar 28, 2026
Dose Recommendation of Remimazolam Tosilate for General Anesthesia in Children and Adolescents: Synergistic Combination of PopPK and PBPK Approaches.

Qiong-Yue Liang, Hui-Hui Hu, Nassim Djebli

|Jul 04, 2025
Prediction of a CLDN18.2 Targeted Antibody Drug Conjugate Pharmacokinetics in Cancer Patients Using PBPK Modeling and Simulation.

Chiara Zunino, Sichen Wang, Yanyan Zhang

|Mar 31, 2025
Middle-Out Physiologically Based Pharmacokinetic Modeling to Support Pediatric Dosing Recommendation for Alectinib.

Tamara van Donge, Elena Guerini, Amaury O'Jeanson

|May 07, 2024
Population pharmacokinetics of adebrelimab - Support of alternative flat dose regimen in extensive-stage small-cell lung cancer.

Peng Chen, Yanyan Zhang, Yike Wang

|Dec 03, 2023
Evaluation of the potential impact on pharmacokinetics of various cytochrome P450 substrates of increasing IL-6 levels following administration of the T-cell bispecific engager glofitamab.

Nassim Djebli, Neil Parrott, Felix Jaminion

Pageof 2

Frequent Collaborators

2 joint publications

Neil Parrott

1 joint publications

Tamara van Donge

1 joint publications

Amaury O'Jeanson

1 joint publications

Cordula Stillhart